Literature DB >> 7910158

Dosimetry of 210Po in humans, caribou, and wolves in northern Canada.

P A Thomas1.   

Abstract

Effective doses from 210Po intake with caribou meat were determined for human residents in Baker Lake and Snowdrift in the Northwest Territories of Canada and compared to doses calculated from reported 210Po tissue activities in Alaskan and British residents (Hill 1966; Blanchard and Moore 1971). Effective doses were calculated to separate body tissues, using ICRP 60 human weighting factors and the ICRP 30 metabolic model for 210Po. Baker Lake and Alaskan effective doses were similar at 0.4 mSv y-1 and slightly higher than Snowdrift doses (0.3 mSv y-1). Alaskan tissue activities indicated higher effective doses to liver, bone surfaces and red marrow and lower doses to spleen than the 210Po metabolic model (ICRP 1979a) predicts. Effective doses to Baker Lake and Snowdrift caribou and wolves, calculated from tissue activities, ranged from 7-20 mSv y-1, using human weighting factors for comparison to human doses only. Effective doses to northern Canadians and wildlife were, respectively, 7-11% and 1.8-5 times an estimated human background of 4 mSv y-1 from all sources.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910158     DOI: 10.1097/00004032-199406000-00007

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  3 in total

1.  Natural variation in 210Po and 210Pb activity concentrations in the urine of Finnish population groups.

Authors:  Maarit Muikku; Tarja Heikkinen; Dina Solatie; Pia Vesterbacka
Journal:  Radiat Environ Biophys       Date:  2011-09-16       Impact factor: 1.925

2.  Radionuclides in the lichen-caribou-human food chain near uranium mining operations in northern Saskatchewan, Canada.

Authors:  P A Thomas; T E Gates
Journal:  Environ Health Perspect       Date:  1999-07       Impact factor: 9.031

Review 3.  Sources of Polonium 210Po and Radio-Lead 210Pb in Human Body in Poland.

Authors:  Alicja Boryło; Bogdan Skwarzec; Jarosław Wieczorek
Journal:  Int J Environ Res Public Health       Date:  2022-02-10       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.